Vitamin D3 supplementation shapes the composition of gut microbiota and improves some obesity parameters induced by high-fat diet in mice.

Purpose: Individuals with vitamin D (VD) insufficiency have a greater tendency to develop obesity and have increased systemic inflammation. Gut microbiota are involved in the regulation of host inflammation and energy metabolism, which plays a role in the pathogenesis of obesity. Thus, we aimed to e...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Nutrition Vol. 63; no. 1; pp. 155 - 173
Autores principales: Xiang, Lian, Du, Tingwan, Zhang, Jingjing, Zhang, Yuanfan, Zhou, Yanqiu, Zhao, Yueying, Zhou, Yong, Ma, Ling
Formato: research tables/charts Journal Article
Publicado: Springer Nature Feb2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=174918769&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 174918769
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14366207
        CR0
      jtl: European Journal of Nutrition
      issn: 14366207
      maglogo: N
    pubinfo:
      dt: Feb2024
      vid: 63
      iid: 1
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        174918769
        172271701
        174918769
        174918769
        10.1007/s00394-023-03246-1
        174918769
      ppf: 155
      ppct: 18
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Vitamin D3 supplementation shapes the composition of gut microbiota and improves some obesity parameters induced by high-fat diet in mice.
      aug:
        au:
          Xiang, Lian
          Du, Tingwan
          Zhang, Jingjing
          Zhang, Yuanfan
          Zhou, Yanqiu
          Zhao, Yueying
          Zhou, Yong
          Ma, Ling
        affil: https://ror.org/00g2rqs52 Department of Nutrition and Food Hygiene, School of Public Health, Southwest Medical University, Luzhou, China
      sug:
        subj:
          Gut Microbiota Metabolism
          Obesity Prevention and Control
          Dietary Fiber Administration and Dosage
          Obesity Drug Therapy
          Cholecalciferol Therapeutic Use
          Diet Adverse Effects
          Treatment Outcomes
          Dietary Supplements
          Cholecalciferol Pharmacodynamics
          Animal Studies
          Rats
          Descriptive Statistics
          RNA Analysis
          Body Weight Drug Effects
          Lipids Drug Effects
          Tumor Necrosis Factor Drug Effects
          Interleukins Drug Effects
          Bacteria Drug Effects
          Funding Source
      ab: Purpose: Individuals with vitamin D (VD) insufficiency have a greater tendency to develop obesity and have increased systemic inflammation. Gut microbiota are involved in the regulation of host inflammation and energy metabolism, which plays a role in the pathogenesis of obesity. Thus, we aimed to evaluate the effects of different doses of VD3 on body weight, serum lipids, inflammatory factors, and intestinal barrier function in obese mice and to explore the regulatory effect of VD3 on gut microbiota in obese mice. Methods: Male C57BL/6 J mice received a normal chow diet (NCD, 10% fat) or high-fat diet (HFD, 60% fat) to induce obesity within 10 weeks. Then, HFD mice were supplemented with 5650, 8475, or 11,300 IU VD3/kg diet for 8 weeks. Finally, 16 s rRNA analysis was performed to analyze gut microbiota composition in cecal contents. In addition, body weight, serum lipids, inflammatory factors, and intestinal barrier function were analyzed. Results: VD3 supplementation reduced body weight and the levels of TG, TC, HDL-C, TNF-α, IL-1β and LPS, and increased ZO-1 in HFD-fed mice. Moreover, it increased α-diversity, reduced F/B ratio and altered microbiota composition by increasing relative abundance of Bacteroidetes, Proteobacteria, Desulfovibrio, Dehalobacterium, Odoribacter, and Parabacteroides and reducing relative abundance of Firmicutes and Ruminococcus. There were significant differences between HFD and NCD groups in several metabolic pathways, including endotoxin biosynthesis, tricarboxylic acid cycle, lipid synthesis and metabolism, and glycolysis. Conclusions: Low, medium, and high doses of VD3 inhibited weight gain, reduced levels of blood lipids and inflammatory factors, and improved endotoxemia and gut barrier function in obese mice. It also increased the α-diversity of gut microbiota in obese mice and reduced the relative abundance of some intestinal pathogenic bacteria, increased the relative abundance of some beneficial bacteria, and corrected the intestinal flora disorder of obese mice, with the low- and high-dose groups showing better effects than the medium-dose group.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N